New drug DW5524 tested in healthy people for first time
NCT ID NCT07349589
First seen Jan 25, 2026 · Last updated Jun 20, 2026 · Updated 27 times
Summary
This early-phase trial will test the safety and how the body handles a single dose of DW5524 in 48 healthy adults. Participants will be randomly assigned to receive either DW5524 or a related version, DW5524-A. The study aims to understand the drug's effects and how it moves through the body, but does not intend to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DW5524
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.